Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Clinician Engagement and Guideline Development: Enhancing an Evidence-Based Culture for Quality Cancer Care-The 2017 Joseph V. Simone Award and Lecture.

Browman GP.

J Oncol Pract. 2017 Aug;13(8):547-551. doi: 10.1200/JOP.2017.023796. Epub 2017 Jun 14. No abstract available.

PMID:
28613968
2.

Innovations in American Society of Clinical Oncology Practice Guideline Development.

Somerfield MR, Bohlke K, Browman GP, Denduluri N, Einhaus K, Hayes DF, Khorana AA, Miller RS, Mohile SG, Oliver TK, Ortiz E, Lyman GH.

J Clin Oncol. 2016 Sep 10;34(26):3213-20. doi: 10.1200/JCO.2016.68.3524. Epub 2016 Jul 5.

PMID:
27382097
3.

A Time-Trend Economic Analysis of Cancer Drug Trials.

Cressman S, Browman GP, Hoch JS, Kovacic L, Peacock SJ.

Oncologist. 2015 Jul;20(7):729-36. doi: 10.1634/theoncologist.2014-0437. Epub 2015 Jun 1.

4.

When is good, good enough? Methodological pragmatism for sustainable guideline development.

Browman GP, Somerfield MR, Lyman GH, Brouwers MC.

Implement Sci. 2015 Mar 6;10:28. doi: 10.1186/s13012-015-0222-4.

5.

Improving the quality of 'personalized medicine' research and practice: through an ethical lens.

Browman GP, Vollmann J, Virani A, Schildmann J.

Per Med. 2014 Jun;11(4):413-423. doi: 10.2217/pme.14.17.

PMID:
29783476
6.

Special series on comparative effectiveness research: challenges to real-world solutions to quality improvement in personalized medicine.

Browman GP.

J Clin Oncol. 2012 Dec 1;30(34):4188-91. doi: 10.1200/JCO.2012.44.8225. Epub 2012 Oct 15. No abstract available.

PMID:
23071250
7.
8.

The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium.

J Clin Epidemiol. 2012 May;65(5):526-34. doi: 10.1016/j.jclinepi.2011.10.008. Epub 2011 Dec 19.

PMID:
22189163
9.

Guideline adaptation: an approach to enhance efficiency in guideline development and improve utilisation.

Fervers B, Burgers JS, Voellinger R, Brouwers M, Browman GP, Graham ID, Harrison MB, Latreille J, Mlika-Cabane N, Paquet L, Zitzelsberger L, Burnand B; ADAPTE Collaboration.

BMJ Qual Saf. 2011 Mar;20(3):228-36. doi: 10.1136/bmjqs.2010.043257. Epub 2011 Jan 5.

PMID:
21209134
10.

AGREE II: advancing guideline development, reporting, and evaluation in health care.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium.

Prev Med. 2010 Nov;51(5):421-4. doi: 10.1016/j.ypmed.2010.08.005. Epub 2010 Aug 20. No abstract available.

PMID:
20728466
11.

AGREE II: advancing guideline development, reporting and evaluation in health care.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium.

J Clin Epidemiol. 2010 Dec;63(12):1308-11. doi: 10.1016/j.jclinepi.2010.07.001. Epub 2010 Jul 24. No abstract available.

PMID:
20656455
12.

AGREE II: advancing guideline development, reporting and evaluation in health care.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium.

CMAJ. 2010 Dec 14;182(18):E839-42. doi: 10.1503/cmaj.090449. Epub 2010 Jul 5. Review. No abstract available.

13.

Development of the AGREE II, part 1: performance, usefulness and areas for improvement.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Hanna SE, Makarski J; AGREE Next Steps Consortium.

CMAJ. 2010 Jul 13;182(10):1045-52. doi: 10.1503/cmaj.091714. Epub 2010 May 31.

14.

Development of the AGREE II, part 2: assessment of validity of items and tools to support application.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Hanna SE, Makarski J; AGREE Next Steps Consortium.

CMAJ. 2010 Jul 13;182(10):E472-8. doi: 10.1503/cmaj.091716. Epub 2010 May 31.

15.
16.

Evidence-based clinical practice guideline development: principles, challenges, and accountability to evidence.

Browman GP.

J Surg Oncol. 2010 Jan 1;101(1):1-2. doi: 10.1002/jso.21419. No abstract available.

PMID:
20025070
17.

The role of guidelines in quality improvement for cancer surgery.

Browman GP, Brouwers M.

J Surg Oncol. 2009 Jun 15;99(8):467-9. doi: 10.1002/jso.21171.

PMID:
19466734
18.

Prognostic tools for cancer survival: a secondary role for quality-of-life measurement.

Browman GP, Berrang T, Smith S.

J Clin Oncol. 2009 Jun 20;27(18):2902-4. doi: 10.1200/JCO.2009.21.8438. Epub 2009 May 18. No abstract available.

PMID:
19451423
19.

A for effort: learning from the application of the GRADE approach to cancer guideline development.

Brouwers MC, Somerfield MR, Browman GP.

J Clin Oncol. 2008 Mar 1;26(7):1025-6. doi: 10.1200/JCO.2007.14.6373. No abstract available.

PMID:
18309937
20.

Accounting for reasonableness: Exploring the personal internal framework affecting decisions about cancer drug funding.

Sinclair S, Hagen NA, Chambers C, Manns B, Simon A, Browman GP.

Health Policy. 2008 May;86(2-3):381-90. doi: 10.1016/j.healthpol.2007.12.003. Epub 2008 Feb 19.

PMID:
18243395
21.

6-STEPPPs: A Modular Tool to Facilitate Clinician Participation in Fair Decisions for Funding New Cancer Drugs.

Browman GP, Manns B, Hagen N, Chambers CR, Simon A, Sinclair S.

J Oncol Pract. 2008 Jan;4(1):2-7. doi: 10.1200/JOP.0812001.

22.

Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus.

Hao D, Ritter MA, Oliver T, Browman GP.

Semin Radiat Oncol. 2006 Jan;16(1):10-9. Review.

PMID:
16378902
23.

Clinical practice guidelines and healthcare decisions: credibility gaps and unfulfilled promises?

Browman GP.

Nat Clin Pract Oncol. 2005 Oct;2(10):480-1. Review. No abstract available.

PMID:
16205747
24.

Evaluating the role of quality assessment of primary studies in systematic reviews of cancer practice guidelines.

Brouwers MC, Johnston ME, Charette ML, Hanna SE, Jadad AR, Browman GP.

BMC Med Res Methodol. 2005 Feb 16;5(1):8.

25.

Standards of proof, standards of practice, and proof of standards: a tale of two trials.

Browman GP.

J Clin Oncol. 2005 Apr 20;23(12):2583-5. Epub 2005 Feb 14. No abstract available.

PMID:
15710950
26.

Practitioners as experts: the influence of practicing oncologists "in-the-field" on evidence-based guideline development.

Browman GP, Makarski J, Robinson P, Brouwers M.

J Clin Oncol. 2005 Jan 1;23(1):113-9.

PMID:
15625366
27.

Clinicians' assessments of practice guidelines in oncology: the CAPGO survey.

Brouwers MC, Graham ID, Hanna SE, Cameron DA, Browman GP.

Int J Technol Assess Health Care. 2004 Fall;20(4):421-6.

PMID:
15609790
28.

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR.

J Clin Oncol. 2005 Jan 20;23(3):619-29. Epub 2004 Nov 15. Review.

PMID:
15545664
29.

Keeping cancer guidelines current: results of a comprehensive prospective literature monitoring strategy for twenty clinical practice guidelines.

Johnston ME, Brouwers MC, Browman GP.

Int J Technol Assess Health Care. 2003 Fall;19(4):646-55.

PMID:
15095770
31.

American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting.

Winer EP, Hudis C, Burstein HJ, Bryant J, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gelber R, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP.

J Clin Oncol. 2003 Jul 1;21(13):2597-9. Epub 2003 May 5. No abstract available.

PMID:
12732612
32.

Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study.

Browman GP, Mohide EA, Willan A, Hodson I, Wong G, Grimard L, MacKenzie RG, El-Sayed S, Dunn E, Farrell S.

Head Neck. 2002 Dec;24(12):1031-7.

PMID:
12454940
33.

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.

Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS; American Society of Clinical Oncology. American Society of Hematology.

J Clin Oncol. 2002 Oct 1;20(19):4083-107.

PMID:
12351606
34.

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.

Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS; American Society of Clinical Oncology; Americcan Society of Hematology.

Blood. 2002 Oct 1;100(7):2303-20.

PMID:
12239138
36.

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP.

J Clin Oncol. 2002 Aug 1;20(15):3317-27. Review.

PMID:
12149306
37.

A controlled "before-after" study: impact of a clinical guidelines programme and regional cancer network organization on medical practice.

Ray-Coquard I, Philip T, de Laroche G, Froger X, Suchaud JP, Voloch A, Mathieu-Daudé H, Fervers B, Farsi F, Browman GP, Chauvin F.

Br J Cancer. 2002 Feb 1;86(3):313-21.

38.

Chemotherapy for older patients with newly diagnosed, advanced-stage, aggressive-histology non-Hodgkin lymphoma: a systematic review.

Kouroukis CT, Browman GP, Esmail R, Meyer RM.

Ann Intern Med. 2002 Jan 15;136(2):144-52. Review.

PMID:
11790067
39.

Development and aftercare of clinical guidelines: the balance between rigor and pragmatism.

Browman GP.

JAMA. 2001 Sep 26;286(12):1509-11. No abstract available.

PMID:
11572746
40.

Funding new cancer drugs in Ontario: closing the loop in the practice guidelines development cycle.

Pater JL, Browman GP, Brouwers MC, Nefsky MF, Evans WK, Cowan DH.

J Clin Oncol. 2001 Jul 15;19(14):3392-6.

PMID:
11454887
41.

Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis.

Browman GP, Hodson DI, Mackenzie RJ, Bestic N, Zuraw L; Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group.

Head Neck. 2001 Jul;23(7):579-89.

PMID:
11400247
42.

Trends in hormonal management of prostate cancer: a population-based study in Ontario.

Bondy SJ, Iscoe NA, Rothwell DM, Gort EH, Fleshner NE, Paszat LF, Browman GP.

Med Care. 2001 Apr;39(4):384-96.

PMID:
11329525
44.
45.

[Tools for the practice of evidence based medicine (I). Update in evidence based information resources for clinical practice].

Haynes RB, Sánchez RG, Jadad AR, Browman GP, Gómez de la Cámara A.

Med Clin (Barc). 2000 Sep 9;115(7):258-60. Spanish. No abstract available.

PMID:
11013150
46.

The Internet and evidence-based decision-making: a needed synergy for efficient knowledge management in health care.

Jadad AR, Haynes RB, Hunt D, Browman GP.

CMAJ. 2000 Feb 8;162(3):362-5. Review. No abstract available.

47.

Systematic reviews and meta-analyses on treatment of asthma: critical evaluation.

Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, Stevens R.

BMJ. 2000 Feb 26;320(7234):537-40. Erratum in: BMJ 2000 Apr 8;320(7240):984. BMJ 2000 Jul 29;321(7256):275.

48.

Essence of evidence-based medicine: A case report.

Browman GP.

J Clin Oncol. 1999 Jul;17(7):1969-73.

PMID:
10561246
49.

Science, language, intuition, and the many meanings of quality of life.

Browman GP.

J Clin Oncol. 1999 Jun;17(6):1651-3. No abstract available.

PMID:
10561200
50.

Development of clinical practice guidelines: surgical perspective.

Brouwers MC, Browman GP.

World J Surg. 1999 Dec;23(12):1236-41.

PMID:
10552114

Supplemental Content

Loading ...
Support Center